Carotenoids, inflammation, and oxidative stress-implications of cellular signaling pathways and relation to chronic disease prevention

Nutrition Research

Volumn 34, Issue 11, 2014, Pages 907-929

  Kaulmann, Anouk ^a   Bohn, Torsten ^a  

^a LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY   (Luxembourg)

Author keywords

Carotenes; Chronic diseases; NF B; Nrf2; Transcription factors; Xanthophylls

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; ASTAXANTHIN; BETA CAROTENE; CAPSANTHIN; CAROTENOID; CROCETIN; CROCIN; FUCOXANTHIN; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; KELCH LIKE ECH ASSOCIATED PROTEIN 1; LYCOPENE; MITOGEN ACTIVATED PROTEIN KINASE; PEPPER EXTRACT; PLACEBO; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; RETINOIC ACID; RETINOL; RETINOL PALMITATE; SELENIUM; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR NF E2; TRANSCRIPTION FACTOR NRF2; XANTHOPHYLL; ZEAXANTHIN; ZINC; ANTIINFLAMMATORY AGENT; ANTIOXIDANT;

ACUTE KIDNEY FAILURE; AGE RELATED MACULAR DEGENERATION; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTHRITIS; ASTHMA; ATHEROSCLEROSIS; BREAST CANCER; CANCER PREVENTION; CHRONIC DISEASE; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIABETES MELLITUS; DIET SUPPLEMENTATION; DNA DAMAGE; ENDOTOXIN-INDUCED UVEITIS; ENTERIC FEEDING; FRUIT; GENE EXPRESSION; HEMORRHAGIC SHOCK; HUMAN; HYPERHOMOCYSTEINEMIA; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INTRACELLULAR SIGNALING; LIVER TOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOARTHRITIS; OXIDATIVE STRESS; PAW EDEMA; RETINA DEGENERATION; REVIEW; SPINACH; TOMATO JUICE; VEGETABLE; ANIMAL; APOPTOSIS; DIABETES MELLITUS, TYPE 2; DISEASE MODEL; DRUG EFFECTS; GENETICS; METABOLISM; NEOPLASMS; RISK FACTOR; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALIA;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; APOPTOSIS; ATHEROSCLEROSIS; CAROTENOIDS; CELL LINE, TUMOR; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; NEOPLASMS; NF-E2-RELATED FACTOR 2; NF-KAPPA B; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 84922400509     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2014.07.010     Document Type: Review

References (215)

1. Coyne T., Ibiebele T.I., Baade P.D., Dobson A., McClintock C., Dunn S., et al. Diabetes mellitus and serum carotenoids: findings of a population-based study in Queensland, Australia. Am J Clin Nutr 2005, 82:685-693.
2. Hozawa A., Jacobs D.R., Steffes M.W., Gross M.D., Steffen L.M., Lee D.H. Associations of serum carotenoid concentrations with the development of diabetes and with insulin concentration: interaction with smoking: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol 2006, 163:929-937.
3. Britton G. Structure and properties of carotenoids in relation to function. FASEB J 1995, 9:1551-1558.
4. Riccioni G., D'Orazio N., Speranza L., Di I.E., Glade M., Bucciarelli V., et al. Carotenoids and asymptomatic carotid atherosclerosis. J Biol Regul Homeost Agents 2010, 24:447-452.
5. Russo M., Tedesco I., Iacomino G., Palumbo R., Galano G., Russo G.L. Dietary phytochemicals in chemoprevention of cancer. Curr Med Chem - Immun, Endoc & Metab Agents 2005, 5:61-72.
6. Nishino H., Tokuda H., Murakoshi M., Satomi Y., Masuda M., Onozuka M., et al. Cancer prevention by natural carotenoids. Biofactors 2000, 13:89-94.
7. Giovannucci E. A review of epidemiologic studies of tomatoes, lycopene, and prostate cancer. Exp Biol Med (Maywood) 2002, 227:852-859.
8. Nielsen O.H., Rudiger N., Gaustadnes M., Horn T. Intestinal interleukin-8 concentration and gene expression in inflammatory bowel disease. Scand J Gastroenterol 1997, 32:1028-1034.
9. Zimmermann H.W., Seidler S., Gassler N., Nattermann J., Luedde T., Trautwein C., et al. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS One 2013, 6:e21381.
10. Feghali C.A., Wright T.M. Cytokines in acute and chronic inflammation. Front Biosci 1997, 2:d12-d26.
11. Bagga D., Wang L., Farias-Eisner R., Glaspy J.A., Reddy S.T. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci U S A 2003, 100:1751-1756.
12. Abraham G., Sundaram V., Sundaram V., Mathew M., Leslie N., Sathiah V. C-Reactive protein, a valuable predictive marker in chronic kidney disease. Saudi J Kidney Dis Transpl 2009, 20:811-815.
13. Vermeire S., Van A.G., Rutgeerts P. C-reactive protein as a marker for inflammatory bowel disease. Inflamm Bowel Dis 2004, 10:661-665.
14. Allison A.C., Ferluga J., Prydz H., Schorlemmer H.U. The role of macrophage activation in chronic inflammation. Agents Actions 1978, 8:27-35.
15. Al-Haddad S., Riddell R.H. The role of eosinophils in inflammatory bowel disease. Gut 2005, 54:1674-1675.
16. Ricciotti E., FitzGerald G.A. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol 2011, 31:986-1000.
17. Jackson Roberts L., Morrow J.D. Measurement of F2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000, 28:505-513.
18. Leonarduzzi G., Sottero B., Poli G. Oxidized products of cholesterol: dietary and metabolic origin, and proatherosclerotic effects (review). J Nutr Biochem 2002, 13:700-710.
19. Del R.D., Stewart A.J., Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005, 15:316-328.
20. Saukkonen K., Sande S., Cioffe C., Wolpe S., Sherry B., Cerami A., et al. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J Exp Med 1990, 171:439-448.
21. Tripoli E., Giammanco M., Tabacchi G., Di M.D., Giammanco S., La G.M. The phenolic compounds of olive oil: structure, biological activity and beneficial effects on human health. Nutr Res Rev 2005, 18:98-112.
22. Yao L.H., Jiang Y.M., Shi J., Tomas-Barberan F.A., Datta N., Singanusong R., et al. Flavonoids in food and their health benefits. Plant Foods Hum Nutr 2004, 59:113-122.
23. Hamer M., Chida Y. Intake of fruit, vegetables, and antioxidants and risk of type 2 diabetes: systematic review and meta-analysis. J Hypertens 2007, 25:2361-2369.
24. Hu F., Wang Y.B., Zhang W., Liang J., Lin C., Li D., et al. Carotenoids and breast cancer risk: a meta-analysis and meta-regression. Breast Cancer Res Treat 2012, 131:239-253.
25. Olmedilla B., Granado F., Southon S., Wright A.J., Blanco I., Gil-Martinez E., et al. Serum concentrations of carotenoids and vitamins A, E, and C in control subjects from five European countries. Br J Nutr 2001, 85:227-238.
26. Scalbert A., Williamson G. Dietary intake and bioavailabilty of polyphenols. J Nutr 2000, 130:2073-2085.
27. Klotz U. Pharmacokinetics and drug metabolism in ther elderly. Drug Metab Rev 2009, 41:67-76.
28. Manach C., Williamson G., Morand C., Scalbert A., Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005, 81:230S-242S.
29. Rock C.L., Swendseid M.E., Jacob R.A., McKee R.W. Plasma carotenoid levels in human subjects fed a low carotenoid diet. J Nutr 1992, 122:96-100.
30. Mayne S.T. Beta-carotene, carotenoids, and disease prevention in humans. FASEB J 1996, 10:690-701.
31. Ge X.X., Xing M.Y., Yu L.F., Shen P. Carotenoid intake and esophageal cancer risk: a meta-analysis. Asian Pac J Cancer Prev 2013, 14:1911-1918.
32. Arnlov J., Zethelius B., Riserus U., Basu S., Berne C., Vessby B., et al. Serum and dietary beta-carotene and alpha-tocopherol and incidence of type 2 diabetes mellitus in acommunity-based study of Swedish men: report from the Uppsala Longitudinal Study of Adult Men (ULSAM) study. Diabetologia 2009, 52:97-105.
33. Wendland B.E., Aghdassi E., Tam C., Carrrier J., Steinhart A.H., Wolman S.L., et al. Lipid peroxidation and plasmaantioxidant micronutrients in Crohn disease. Am J Clin Nutr 2001, 74:259-264.
34. Xu X., Yu E., Liu L., Zhang W., Wei X., Gao X., et al. Dietary intake of vitamins A, C, and E and the risk of colorectal adenoma: a meta-analysis of observational studies. Eur J Cancer Prev 2013, 22:529-539.
35. Bohn T. Bioavailability of non-provitamin A carotenoids. Curr Nutr Fd Sci 2008, 4:240-258.
36. Mueller L., Boehm V. Antioxidant activity of beta-carotene compounds in different in vitro assays. Molecules 2011, 16:1055-1069.
37. Biehler E., Alkerwi A., Hoffmann L., Krause E., Guillaume M., Lair M.L., et al. Contribution of violaxanthin, neoxanthin, phytoene and phytofluene to total carotenoid intake: assessment in Luxembourg. J Food Comp Anal 2012, 25:56-65.
38. Waris G., Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog 2006, 5:14. 10.1186/1477-3163-5-14.
39. Liaaen-Jensen S., Lutneos B.F. Structure and properties of carotenoid cation. Carotenoids, natural functions 2008, 155-166. Birkhäuser Verlag, Basel. G. Britton, S. Liaaen-Jensen, H. Pfander (Eds.).
40. Yeum K.J., Aldini G., Russell R.M., Krinsky N.I. Antioxidant/pro-oxidant Actions of Carotenoids. Volume 5: Nutrition and Health 2009, 235-268. Birkhäuser, Basel. G. Britton, S. Liaaen-Jensen, H. Pfander (Eds.).
41. Bouayed J., Bohn T. Dietary derived antioxidants: implications on health. Nutrition, Well-Being and Health 2012, 1-22. InTech, Croatia. J. Bouayed, T. Bohn (Eds.).
42. Woodall A.A., Lee S.W., Weesie R.J., Jackson M.J., Britton G. Oxidation of carotenoids by free radicals: relationship between structure and reactivity. Biochim Biophys Acta 1997, 1336:33-42.
43. Stahl W., Sies H. Antioxidant activity of carotenoids. Mol Aspects Med 2003, 24:345-351.
44. Stahl W., Junghans A., de Boer B., Driomina E.S., Briviba K., Sies H. Carotenoid mixtures protect multilamellar liposomes against oxidative damage: synergistic effects of lycopene and lutein. FEBS Lett 1998, 427:305-308.
45. Gruszecki W.I. Carotenoids in lipid membranes. Carotenoids, physical, chemical, and biological functions and properties 2010, 19-30. Taylor and Francis Group, New York. J.T. Landrum (Ed.).
46. El-Agamey A., McGarvey D.J. Carotenoid Radicals and Radical Ions. Carotenoids, volume 4: natural functions 2008, 119-154. Birkhäuser, Basel. G. Britton, S. Liaaen-Jensen, H. Pfander (Eds.).
47. Chew B.P., Wong T.S., Michal J.J., Standaert F.E., Heirman L.R. Subcellular distribution of beta-carotene, retinol, andalpha-tocopherol in porcine lymphocytes after a single injection of beta-carotene. J Anim Sci 1991, 69:4892-4897.
48. Havaux M. Carotenoids as membrane stabilizers in chloroplasts. Trends Plant Sci 1998, 3(4):147-151.
49. Gruszecki W.I., Strzalka K. Carotenoids as modulators of lipid membrane physical properties. Biochim Biophys Acta 2005, 1740:108-115.
50. Agarwal S., Rao A.V. Tomato lycopene and low density lipoprotein oxidation: a human dietary intervention study. Lipids 1998, 33:981-984.
51. Ben-Dor A., Steiner M., Gheber L., Danilenko M., Dubi N., Linnewiel K., et al. Carotenoids activate the antioxidant response element transcription system. Mol Cancer Ther 2005, 4:177-186.
52. Palozza P., Serini S., Torsello A., Di N.F., Piccioni E., Ubaldi V., et al. Beta-carotene regulates NF-kappaB DNA-binding activity by a redox mechanism in human leukemia and colon adenocarcinoma cells. J Nutr 2003, 133:381-388.
53. Borel P. Genetic variations involved in interindividual variability in carotenoid status. Mol Nutr Food Res 2012, 56:228-240.
54. Khansari N., Shakiba Y., Mahmoudi M. Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat Inflamm Allergy Drug Discov 2009, 3:73-80.
55. Reuter S., Gupta S.C., Chaturvedi M.M., Aggarwal B.B. Oxidative stress, inflammation, and cancer: how are they linked?. Free Radic Biol Med 2010, 49:1603-1616.
56. Kurylowicz A., Nauman J. The role of nuclear factor-kappaB in the development of autoimmune diseases: a link between genes and environment. Acta Biochim Pol 2008, 55:629-647.
57. McConnell B.B., Yang V.W. The role of inflammation in the pathogenesis of colorectal cancer. Curr Colorectal Cancer Rep 2009, 5:69-74.
58. Kim J., Cha Y.N., Surh Y.J. A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders. Mutat Res 2010, 690:12-23.
59. Kansanen E., Kuosmanen S.M., Leinonen H., Levonen A.L. The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biol 2013, 1:45-49.
60. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298:1911-1912.
61. Kyriakis J.M., Avruch J. Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev 2012, 92:689-737.
62. Schaeffer H.J., Weber M.J. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 1999, 19:2435-2444.
63. Kaulmann A., Serchi T., Renaut J., Hoffmann L., Bohn T. Carotenoid exposure of Caco-2 intestinal epithelial cells did not affect selected inflammatory markers but altered their proteomic response. Br J Nutr 2012, 108:963-973.
64. Romier-Crouzet B., Van De W.J., During A., Joly A., Rousseau C., Henry O., et al. Inhibition of inflammatory mediators by polyphenolic plant extracts in human intestinal Caco-2 cells. Food Chem Toxicol 2009, 47:1221-1230.
65. Ajuwon K.M., Spurlock M.E. Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am J Physiol Regul Integr Comp Physiol 2005, 288:R1220-R1225.
66. Li H., Ruan X.Z., Powis S.H., Fernando R., Mon W.Y., Wheeler D.C., et al. EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism. Kidney Int 2005, 67:867-874.
67. Lin W., Wu R.T., Wu T., Khor T.O., Wang H., Kong A.N. Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway. Biochem Pharmacol 2008, 76:967-973.
68. Choi Y.H., Back K.O., Kim H.J., Lee S.Y., Kook K.H. Pirfenidone attenuates IL-1beta-induced COX-2 and PGE2 production in orbital fibroblasts through suppression of NF-kappaB activity. Exp Eye Res 2013, 113:1-8.
69. Yoon J.S., Chae M.K., Lee S.Y., Lee E.J. Anti-inflammatory effect of quercetin in a whole orbital tissue culture of Graves' orbitopathy. Br J Ophthalmol 2012, 96:1117-1121.
70. Duthie S.J., Collins A.R., Duthie G.G., Dobson V.L. Quercetin and myricetin protect against hydrogen peroxide-induced DNA damage (strand breaks and oxidised pyrimidines) in human lymphocytes. Mutat Res 1997, 393:223-231.
71. Yamamoto K., Kushima R., Kisaki O., Fujiyama Y., Okabe H. Combined effect of hydrogen peroxide induced oxidative stress and IL-1 alpha on IL-8 production in CaCo-2 cells (a human colon carcinoma cell line) and normal intestinal epithelial cells. Inflammation 2003, 27:123-128.
72. Khair O.A., Davies R.J., Devalia J.L. Bacterial-induced release of inflammatory mediators by bronchial epithelial cells. Eur Respir J 1996, 9:1913-1922.
73. Lee H.S., Lee C.S., Yang C.J., Su S.L., Salter D.M. Candida albicans induces cyclo-oxygenase 2 expression and prostaglandin E2 production in synovial fibroblasts through an extracellular-regulated kinase 1/2 dependent pathway. Arthritis Res Ther 2009, 11:R48. 10.1186/ar2661.
74. Meusel T.R., Imani F. Viral induction of inflammatory cytokines in human epithelial cells follows a p38 mitogen-activated protein kinase-dependent but NF-kappa B-independent pathway. J Immunol 2003, 171:3768-3774.
75. Koetzler R., Zaheer R.S., Newton R., Proud D. Nitric oxide inhibits IFN regulatory factor 1 and nuclear factor-kappaB pathways in rhinovirus-infected epithelial cells. J Allergy Clin Immunol 2009, 124:551-557.
76. Hanada T., Yoshimura A. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev 2002, 13:413-421.
77. Biehler E., Hoffmann L., Krause E., Bohn T. Divalent minerals decrease micellarization and uptake of carotenoids and digestion products into Caco-2 cells. J Nutr 2011, 141:1769-1776.
78. Ribeiro H.S., Guerrero J.M., Briviba K., Rechkemmer G., Schuchmann H.P., Schubert H. Cellular uptake ofcarotenoid-loaded oil-in-water emulsions in colon carcinoma cells in vitro. J Agric Food Chem 2006, 54:9366-9369.
79. Jang S.H., Lim J.W., Morio T., Kim H. Lycopene inhibits Helicobacter pylori-induced ATM/ATR-dependent DNA damage response in gastric epithelial AGS cells. Free Radic Biol Med 2012, 52:607-615.
80. Jung W.J., Sung M.K. Effects of major dietary antioxidants on inflammatory markers of RAW 264.7 macrophages. Biofactors 2004, 21:113-117.
81. Gouranton E., Thabuis C., Riollet C., Malezet-Desmoulins C., El Y.C., Amiot M.J., et al. Lycopene inhibits proinflammatory cytokine and chemokine expression in adipose tissue. J Nutr Biochem 2011, 22:642-648.
82. Marcotorchino J., Romier B., Gouranton E., Riollet C., Gleize B., Malezet-Desmoulins C., et al. Lycopene attenuatesLPS-induced TNF-alpha secretion in macrophages andinflammatory markers in adipocytes exposed tomacrophage-conditioned media. Mol Nutr Food Res 2012, 56:725-732.
83. Terazawa S., Nakajima H., Shingo M., Niwano T., Imokawa G. Astaxanthin attenuates the UVB-induced secretion ofprostaglandin E2 and interleukin-8 in human keratinocytes by interrupting MSK1 phosphorylation in a ROSdepletion-independent manner. Exp Dermatol 2012, 21:11-17.
84. Bouayed J., Bohn T. Exogenous antioxidants-double-edged swords in cellular redox state: Health beneficial effects at physiologic doses versus deleterious effects at high doses. Oxid Med Cell Longev 2010, 3:228-237.
85. Palozza P., Simone R., Catalano A., Russo M., Bohm V. Lycopene modulation of molecular targets affected by smoking exposure. Curr Cancer Drug Targets 2012, 12:640-657.
86. Simone R.E., Russo M., Catalano A., Monego G., Froehlich K., Boehm V., et al. Lycopene inhibits NF-kB-mediated IL-8 expression and changes redox and PPARgamma signalling in cigarette smoke-stimulated macrophages. PLoS One 2011, 6:e19652. 10.1371/journal.pone.0019652.
87. Kim Y., Seo J.H., Kim H. beta-Carotene and lutein inhibit hydrogen peroxide-induced activation of NF-kappaB and IL-8 expression in gastric epithelial AGS cells. J Nutr Sci Vitaminol (Tokyo) 2011, 57:216-223.
88. Jang S.H., Lim J.W., Kim H. Beta-carotene inhibits Helicobacter pylori-induced expression of inducible nitric oxide synthase and cyclooxygenase-2 in human gastric epithelial AGS cells. J Physiol Pharmacol 2009, 60:131-137.
89. Zangar R.C., Davydov D.R., Verma S. Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol Appl Pharmacol 2004, 199:316-331.
90. Palozza P., Catalano A., Simone R., Cittadini A. Lycopene as a guardian of redox signalling. Acta Biochim Pol 2012, 59:21-25.
91. Armoza A., Haim Y., Bashiri A., Wolak T., Paran E. Tomato extract and the carotenoids lycopene and lutein improve endothelial function and attenuate inflammatory NF-kappaB signaling in endothelial cells. J Hypertens 2013, 31:521-529.
92. Kwok S.K., Park M.K., Cho M.L., Oh H.J., Park E.M., Lee D.G., et al. Retinoic acid attenuates rheumatoid inflammation in mice. J Immunol 2012, 189:1062-1071.
93. Linnewiel-Hermoni K., Ernst H., Caris-Veyrat C., Levy J., Sharoni Y. Carotenoid derivatives inhibit the deleterious NFkB activity in bonde and cancer cells by affecting strategic Thiol groups. The fifth annual meeting of the isreali society for cancer research 2013, 80.
94. Speranza L., Pesce M., Patruno A., Franceschelli S., de Lutiis M.A., Grilli A., et al. Astaxanthin treatment reduced oxidative induced pro-inflammatory cytokines secretion in U937: SHP-1 as a novel biological target. Mar Drugs 2012, 10:890-899.
95. Lin H.W., Chang T.J., Yang D.J., Chen Y.C., Wang M., Chang Y.Y. Regulation of virus-induced inflammatory response by beta-carotene in RAW264.7 cells. Food Chem 2012, 134:2169-2175.
96. Dinkova-Kostova A.T. Phytochemicals as protectors against ultraviolet radiation: versatility of effects and mechanisms. Planta Med 2008, 74:1548-1559.
97. Stahl W., Heinrich U., Jungmann H., Tronnier H., Sies H. Carotenoids in human skin: noninvasive measurement and identification of dermal carotenoids and carotenol esters. Methods Enzymol 2000, 319:494-502.
98. Zhang X., Zhao W.E., Hu L., Zhao L., Huang J. Carotenoids inhibit proliferation and regulate expression of peroxisome proliferators-activated receptor gamma (PPARgamma) in K562 cancer cells. Arch Biochem Biophys 2011, 512:96-106.
99. Linnewiel K., Ernst H., Caris-Veyrat C., Ben-Dor A., Kampf A., Salman H., et al. Structure activity relationship of carotenoid derivatives in activation of the electrophile/antioxidant response element transcription system. Free Radic Biol Med 2009, 47:659-667.
100. Gerhäuser C., Klimo K., Hummer W., Holzer J., Petermann A., Garreta-Rufas A., et al. Identification of3-hydroxy-beta-damascone and related carotenoid-derived aroma compounds as novel potent inducers of Nrf2-mediated phase 2 response with concomitant anti-inflammatory activity. Mol Nutr Food Res 2009, 53:1237-1244.
101. Zhao F., Wu T., Lau A., Jiang T., Huang Z., Wang X.J., et al. Nrf2 promotes neuronal cell differentiation. Free Radic Biol Med 2009, 47:867-879.
102. Tan K.P., Kosuge K., Yang M., Ito S. NRF2 as a determinant of cellular resistance in retinoic acid cytotoxicity. Free Radic Biol Med 2008, 45(12):1663-1673.
103. Wang X.J., Hayes J.D., Henderson C.J., Wolf C.R. Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha. Proc Natl Acad Sci U S A 2007, 104:19589-19594.
104. Liu C.L., Chiu Y.T., Hu M.L. Fucoxanthin enhances HO-1 and NQO1 expression in murine hepatic BNL CL.2 cells through activation of the Nrf2/ARE system partially by its pro-oxidant activity. J Agric Food Chem 2011, 59:11344-11351.
105. Li Z., Dong X., Liu H., Chen X., Shi H., Fan Y., et al. Astaxanthin protects ARPE-19 cells from oxidative stress via upregulation of Nrf2-regulated phase II enzymes through activation of PI3K/Akt. Mol Vis 2013, 19:1656-1666.
106. Snodderly D.M. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr 1995, 62:1448S-1461S.
107. Ye Q., Huang B., Zhang X., Zhu Y., Chen X. Astaxanthin protects against MPP(+)-induced oxidative stress in PC12 cells via the HO-1/NOX2 axis. BMC Neurosci 2012, 13:156. 10.1186/1471-2202-13-156.
108. Johnson E.J., Vishwanathan R., Johnson M.A., Hausman D.B., Davey A., Scott T.M., et al. Relationship between serum and brain carotenoids, alpha-tocopherol, and retinol concentrations and cognitive performance in the oldest old from the Georgia centenarian study. J Aging Res 2013, 2013:951786.
109. Slattery M.L., Lundgreen A., Wolff R.K. Dietary influence on MAPK-signaling pathways and risk of colon and rectal cancer. Nutr Cancer 2013, 65:729-738.
110. Palozza P., Simone R., Catalano A., Boninsegna A., Bohm V., Frohlich K., et al. Lycopene prevents 7-ketocholesterol-induced oxidative stress, cell cycle arrest and apoptosis in human macrophages. J Nutr Biochem 2010, 21:34-46.
111. Feng D., Ling W.H., Duan R.D. Lycopene suppresses LPS-induced NO and IL-6 production by inhibiting the activation of ERK, p38MAPK, and NF-kappaB in macrophages. Inflamm Res 2010, 59:115-121.
112. Biehler E., Bohn T. Methods for assessing aspects of carotenoid bioavailability. Curr Nutr Fd Sci 2010, 6:44-69.
113. Reagan-Shaw S., Nihal M., Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008, 22:659-661.
114. Rossoni Junior J.V., Araujo G.R., Padua B.C., Magalhaes C.L., Chaves M.M., Pedrosa M.L., et al. Annatto extract and beta-carotene enhances antioxidant status and regulate gene expression in neutrophils of diabetic rats. Free Radic Res 2012, 46:329-338.
115. Heber D., Lu Q.Y. Overview of mechanisms of action of lycopene. Exp Biol Med (Maywood) 2002, 227:920-923.
116. Sahin K., Sahin N., Kucuk O. Lycopene and chemotherapy toxicity. Nutr Cancer 2010, 62:988-995.
117. Mansour H.H., Tawfik S.S. Efficacy of lycopene against fluoride toxicity in rats. Pharm Biol 2012, 50:707-711.
118. Yang H., Xu Z., Liu W., Deng Y., Xu B. The protective role of procyanidins and lycopene against mercuric chloride renal damage in rats. Biomed Environ Sci 2011, 24:550-559.
119. Marin D.P., Bolin A.P., Macedo R.C., Sampaio S.C., Otton R. ROS production in neutrophils from alloxan-induced diabetic rats treated in vivo with astaxanthin. Int Immunopharmacol 2011, 11:103-109.
120. Sasaki M., Ozawa Y., Kurihara T., Kubota S., Yuki K., Noda K., et al. Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes. Diabetologia 2010, 53:971-979.
121. Nakajima Y., Inokuchi Y., Shimazawa M., Otsubo K., Ishibashi T., Hara H. Astaxanthin, a dietary carotenoid, protects retinal cells against oxidative stress in-vitro and in mice in-vivo. J Pharm Pharmacol 2008, 60:1365-1374.
122. Park J.S., Mathison B.D., Hayek M.G., Zhang J., Reinhart G.A., Chew B.P. Astaxanthin modulates age-associated mitochondrial dysfunction in healthy dogs. J Anim Sci 2013, 91:268-275.
123. Park Y.O., Hwang E.S., Moon T.W. The effect of lycopene on cell growth and oxidative DNA damage of Hep3B human hepatoma cells. Biofactors 2005, 23:129-139.
124. Astorg P. Food carotenoids and cancer prevention: an overview of current research. Trends Food Sci Tech 1997, 8:406-413.
125. Breinholt V., Lauridsen S.T., Daneshvar B., Jakobsen J. Dose-response effects of lycopene on selecteddrug-metabolizing and antioxidant enzymes in the rat. Cancer Lett 2000, 154:201-210.
126. Aung H.H., Vasu V.T., Valacchi G., Corbacho A.M., Kota R.S., Lim Y., et al. Effects of dietary carotenoids on mouse lung genomic profiles and their modulatory effects on short-term cigarette smoke exposures. Genes Nutr 2009, 4:23-39.
127. Harari A., Harats D., Marko D., Cohen H., Barshack I., Kamari Y., et al. A 9-cis beta-carotene-enriched diet inhibits atherogenesis and fatty liver formation in LDL receptor knockout mice. J Nutr 2008, 138:1923-1930.
128. van Helden Y.G., Godschalk R.W., van Schooten F.J., Keijer J. Organ specificity of beta-carotene induced lunggene-expression changes in Bcmo1-/- mice. Mol Nutr Food Res 2013, 57:307-319.
129. Liu W.S., Chen M.C., Chiu K.H., Wen Z.H., Lee C.H. Amelioration of dextran sodium sulfate-induced colitis in mice by Rhodobacter sphaeroides extract. Molecules 2012, 17:13622-13630.
130. Kuhad A., Sethi R., Chopra K. Lycopene attenuates diabetes-associated cognitive decline in rats. Life Sci 2008, 83:128-134.
131. Liu X., Qu D., He F., Lu Q., Wang J., Cai D. Effect of lycopene on the vascular endothelial function and expression of inflammatory agents in hyperhomocysteinemic rats. Asia Pac J Clin Nutr 2007, 16:244-248.
132. Wang Y., Wang V.M., Chan C.C. The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment. Eye (Lond) 2011, 25:127-139.
133. Carpentier S., Knaus M., Suh M. Associations between lutein, zeaxanthin, and age-related macular degeneration: an overview. Crit Rev Food Sci Nutr 2009, 49:313-326.
134. Kijlstra A., Tian Y., Kelly E.R., Berendschot T.T. Lutein: more than just a filter for blue light. Prog Retin Eye Res 2012, 31:303-315.
135. Jin X.H., Ohgami K., Shiratori K., Suzuki Y., Hirano T., Koyama Y., et al. Inhibitory effects of lutein on endotoxin-induced uveitis in Lewis rats. Invest Ophthalmol Vis Sci 2006, 47:2562-2568.
136. Shiratori K., Ohgami K., Ilieva I., Jin X.H., Koyama Y., Miyashita K., et al. Effects of fucoxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Exp Eye Res 2005, 81:422-428.
137. Izumi-Nagai K., Nagai N., Ohgami K., Satofuka S., Ozawa Y., Tsubota K., et al. Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin. Invest Ophthalmol Vis Sci 2008, 49:1679-1685.
138. Jnaneshwari S., Hemshekhar M., Santhosh M.S., Sunitha K., Thushara R., Thirunavukkarasu C., et al. Crocin, a dietary colorant, mitigates cyclophosphamide-induced organ toxicity by modulating antioxidant status and inflammatory cytokines. J Pharm Pharmacol 2013, 65:604-614.
139. Hemshekhar M., Sebastin S.M., Sunitha K., Thushara R.M., Kemparaju K., Rangappa K.S., et al. A dietary colorant crocin mitigates arthritis and associated secondary complications by modulating cartilage deteriorating enzymes, inflammatory mediators and antioxidant status. Biochimie 2012, 94:2723-2733.
140. Wang Y., Yan J., Xi L., Qian Z., Wang Z., Yang L. Protective effect of crocetin on hemorrhagic shock-induced acute renal failure in rats. Shock 2012, 38:63-67.
141. Choi S.Y., Park J.H., Kim J.S., Kim M.K., Aruoma O.I., Sung M.K. Effects of quercetin and beta-carotene supplementation on azoxymethane-induced colon carcinogenesis and inflammatory responses in rats fed with high-fat diet rich in omega-6 fatty acids. Biofactors 2006, 27:137-146.
142. Takahashi K., Takimoto T., Sato K., Akiba Y. Effect of dietary supplementation of astaxanthin from Phaffia rhodozyma on lipopolysaccharide-induced early inflammatory responses in male broiler chickens (Gallus gallus) fed a corn-enriched diet. Anim Sci J 2011, 82:753-758.
143. Veeramachaneni S., Ausman L.M., Choi S.W., Russell R.M., Wang X.D. High dose lycopene supplementation increases hepatic cytochrome P4502E1 protein and inflammation in alcohol-fed rats. J Nutr 2008, 138:1329-1335.
144. Yeh S., Hu M. Antioxidant and pro-oxidant effects of lycopene in comparison with beta-carotene on oxidant-induced damage in Hs68 cells. J Nutr Biochem 2000, 11:548-554.
145. Sahin K., Tuzcu M., Sahin N., Ali S., Kucuk O. Nrf2/HO-1 signaling pathway may be the prime target for chemoprevention of cisplatin-induced nephrotoxicity by lycopene. Food Chem Toxicol 2010, 48:2670-2674.
146. Tripathi D.N., Jena G.B. Astaxanthin intervention ameliorates cyclophosphamide-induced oxidative stress, DNA damage and early hepatocarcinogenesis in rat: role of Nrf2, p53, p38 and phase-II enzymes. Mutat Res 2010, 696:69-80.
147. James M.L., Ross A.C., Nicola T., Steele C., Ambalavanan N. VARA attenuates hyperoxia-induced impaired alveolar development and lung function in newborn mice. Am J Physiol Lung Cell Mol Physiol 2013, 304:L803-L812.
148. Hengesbach L.M., Hoag K.A. Physiological concentrations of retinoic acid favor myeloid dendritic cell development over granulocyte development in cultures of bone marrow cells from mice. J Nutr 2004, 134:2653-2659.
149. Kinoshita K., Yoo B.S., Nozaki Y., Sugiyama M., Ikoma S., Ohno M., et al. Retinoic acid reduces autoimmune renal injury and increases survival in NZB/WF1 mice. J Immunol 2003, 170:5793-5798.
150. Dzhagalov I., Chambon P., He Y.W. Regulation of CD8+ T lymphocyte effector function and macrophage inflammatory cytokine production by retinoic acid receptor gamma. J Immunol 2007, 178:2113-2121.
151. Shuai K., Liu B. Regulation of JAK-STAT signalling in the immune system. Nat Rev Immunol 2003, 3:900-911.
152. Van Y.H., Lee W.H., Ortiz S., Lee M.H., Qin H.J., Liu C.P. All-trans retinoic acid inhibits type 1 diabetes by T regulatory(Treg)-dependent suppression ofinterferon-gamma-producing T-cells without affecting Th17 cells. Diabetes 2009, 58:146-155.
153. Aydemir G., Carlsen H., Blomhoff R., Ruhl R. Lycopene induces retinoic acid receptor transcriptional activation in mice. Mol Nutr Food Res 2012, 56:702-712.
154. Harrison E.H., dela SC Eroglu A., Fleshman M.K. The formation, occurrence, and function of beta-apocarotenoids: beta-carotene metabolites that may modulate nuclear receptor signaling. Am J Clin Nutr 2012, 96:1189S-1192S.
155. Hernandez-Ortega M., Ortiz-Moreno A., Hernandez-Navarro M.D., Chamorro-Cevallos G., Dorantes-Alvarez L., Necoechea-Mondragon H. Antioxidant, antinociceptive, and anti-inflammatory effects of carotenoids extracted from dried pepper (Capsicum annuum L.). J Biomed Biotechnol 2012, 2012:524019. 10.1155/2012/524019.
156. Lee C.M., Chang J.H., Moon D.O., Choi Y.H., Choi I.W., Park Y.M., et al. Lycopene suppresses ovalbumin-induced airway inflammation in a murine model of asthma. Biochem Biophys Res Commun 2008, 374:248-252.
157. Erlandsson H.H., Andersson U. Mini-review: the nuclear protein HMGB1 as a proinflammatory mediator. Eur J Immunol 2004, 34:1503-1512.
158. Lockwood S.F., Penn M.S., Hazen S.L., Bikadi Z., Zsila F. The effects of oral Cardax (disodium disuccinate astaxanthin) on multiple independent oxidative stress markers in a mouse peritoneal inflammation model: influence on5-lipoxygenase in vitro and in vivo. Life Sci 2006, 79:162-174.
159. Riboli E., Hunt K.J., Slimani N., Ferrari P., Norat T., Fahey M., et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002, 5:1113-1124.
160. Dwyer J.H., Paul-Labrador M.J., Fan J., Shircore A.M., Merz C.N., Dwyer K.M. Progression of carotid intima-media thickness and plasma antioxidants: the Los Angeles Atherosclerosis Study. Arterioscler Thromb Vasc Biol 2004, 24:313-319.
161. Kabagambe E.K., Furtado J., Baylin A., Campos H. Some dietary and adipose tissue carotenoids are associated with the risk of nonfatal acute myocardial infarction in Costa Rica. J Nutr 2005, 135:1763-1769.
162. Ciccone M.M., Cortese F., Gesualdo M., Carbonara S., Zito A., Ricci G., et al. Dietary intake of carotenoids and their antioxidant and anti-inflammatory effects in cardiovascular care. Mediators Inflamm 2013, 2013:782137. 10.1155/2013/782137.
163. Joshipura K.J., Hu F.B., Manson J.E., Stampfer M.J., Rimm E.B., Speizer F.E., et al. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med 2001, 134:1106-1114.
164. He F.J., Nowson C.A., MacGregor G.A. Fruit and vegetable consumption and stroke: meta-analysis of cohort studies. Lancet 2006, 367:320-326.
165. Buijsse B., Feskens E.J., Kwape L., Kok F.J., Kromhout D. Both alpha- and beta-carotene, but not tocopherols and vitamin C, are inversely related to 15-year cardiovascular mortality in Dutch elderly men. J Nutr 2008, 138:344-350.
166. Etminan M., Takkouche B., Caamano-Isorna F. The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev 2004, 13:340-345.
167. Mannisto S., Smith-Warner S.A., Spiegelman D., Albanes D., Anderson K., van den Brandt P.A., et al. Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies. Cancer Epidemiol Biomarkers Prev 2004, 13:40-48.
168. Wang Y., Chun O.K., Song W.O. Plasma and dietary antioxidant status as cardiovascular disease risk factors: a review of human studies. Nutrients 2013, 5:2969-3004.
169. Bjelakovic G., Nikolova D., Gluud L.L., Simonetti R.G., Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007, 297:842-857.
170. Palozza P., Serini S., Trombino S., Lauriola L., Ranelletti F.O., Calviello G. Dual role of beta-carotene in combination with cigarette smoke aqueous extract on the formation of mutagenic lipid peroxidation products in lung membranes: dependence on pO2. Carcinogenesis 2006, 27:2383-2391.
171. Omenn G.S., Goodman G.E., Thornquist M.D., Balmes J., Cullen M.R., Glass A., et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1996, 88:1550-1559.
172. Albanes D., Heinonen O.P., Taylor P.R., Virtamo J., Edwards B.K., Rautalahti M., et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in thealpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996, 88:1560-1570.
173. Satia J.A., Littman A., Slatore C.G., Galanko J.A., White E. Long-term use of beta-carotene, retinol, lycopene, and luteinsupplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study. Am J Epidemiol 2009, 169:815-828.
174. Leppala J.M., Virtamo J., Fogelholm R., Huttunen J.K., Albanes D., Taylor P.R., et al. Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers. Arterioscler Thromb Vasc Biol 2000, 20:230-235.
175. Blot W.J., Li J.Y., Taylor P.R., Guo W., Dawsey S., Wang G.Q., et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993, 85:1483-1492.
176. Blot W.J., Li J.Y., Taylor P.R., Guo W., Dawsey S.M., Li B. The Linxian trials: mortality rates by vitamin-mineral intervention group. Am J Clin Nutr 1995, 62:1424S-1426S.
177. Hercberg S., Galan P., Preziosi P., Bertrais S., Mennen L., Malvy D., et al. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 2004, 164:2335-2342.
178. Pool-Zobel B.L., Bub A., Muller H., Wollowski I., Rechkemmer G. Consumption of vegetables reduces genetic damage in humans: first results of a human intervention trial with carotenoid-rich foods. Carcinogenesis 1997, 18:1847-1850.
179. Butalla A.C., Crane T.E., Patil B., Wertheim B.C., Thompson P., Thomson C.A. Effects of a carrot juice intervention on plasma carotenoids, oxidative stress, and inflammation in overweight breast cancer survivors. Nutr Cancer 2012, 64:331-341.
180. Rehman A., Bourne L.C., Halliwell B., Rice-Evans C.A. Tomato consumption modulates oxidative DNA damage in humans. Biochem Biophys Res Commun 1999, 262:828-831.
181. Visioli F., Riso P., Grande S., Galli C., Porrini M. Protective activity of tomato products on in vivo markers of lipid oxidation. Eur J Nutr 2003, 42:201-206.
182. Chen L., Stacewicz-Sapuntzakis M., Duncan C., Sharifi R., Ghosh L., van B.R., et al. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J Natl Cancer Inst 2001, 93:1872-1879.
183. Kim J.Y., Paik J.K., Kim O.Y., Park H.W., Lee J.H., Jang Y., et al. Effects of lycopene supplementation on oxidative stress and markers of endothelial function in healthy men. Atherosclerosis 2011, 215:189-195.
184. Upritchard J.E., Sutherland W.H., Mann J.I. Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care 2000, 23:733-738.
185. Bohn T., Blackwood M., Francis D., Tian Q., Schwartz S.J., Clinton S.K. Bioavailability of phytochemical constituents from a novel soy fortified lycopene rich tomato juice developed for targeted cancer prevention trials. Nutr Cancer 2013, 65:919-929.
186. Rizwan M., Rodriguez-Blanco I., Harbottle A., Birch-Machin M.A., Watson R.E., Rhodes L.E. Tomato paste rich in lycopene protects against cutaneous photodamage in humans in vivo: a randomized controlled trial. Br J Dermatol 2011, 164:154-162.
187. Devaraj S., Mathur S., Basu A., Aung H.H., Vasu V.T., Meyers S., et al. A dose-response study on the effects of purified lycopene supplementation on biomarkers of oxidative stress. J Am Coll Nutr 2008, 27:267-273.
188. Neyestani T.R., Shariatzadeh N., Gharavi A., Kalayi A., Khalaji N. Physiological dose of lycopene suppressed oxidative stress and enhanced serum levels of immunoglobulin M in patients with type 2 diabetes mellitus: a possible role in the prevention of long-term complications. J Endocrinol Invest 2007, 30:833-838.
189. Zhao X., Aldini G., Johnson E.J., Rasmussen H., Kraemer K., Woolf H., et al. Modification of lymphocyte DNA damage by carotenoid supplementation in postmenopausal women. Am J Clin Nutr 2006, 83:163-169.
190. Torbergsen A.C., Collins A.R. Recovery of human lymphocytes from oxidative DNA damage; the apparent enhancement of DNA repair by carotenoids is probably simply an antioxidant effect. Eur J Nutr 2000, 39:80-85.
191. Watzl B., Bub A., Blockhaus M., Herbert B.M., Luhrmann P.M., Neuhauser-Berthold M., et al. Prolonged tomato juice consumption has no effect on cell-mediated immunity ofwell-nourished elderly men and women. J Nutr 2000, 130:1719-1723.
192. Riso P., Visioli F., Grande S., Guarnieri S., Gardana C., Simonetti P., et al. Effect of a tomato-based drink on markers of inflammation, immunomodulation, and oxidative stress. J Agric Food Chem 2006, 54:2563-2566.
193. Kucuk O., Sarkar F.H., Sakr W., Djuric Z., Pollak M.N., Khachik F., et al. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev 2001, 10:861-868.
194. Denniss S.G., Haffner T.D., Kroetsch J.T., Davidson S.R., Rush J.W., Hughson R.L. Effect of short-term lycopene supplementation and postprandial dyslipidemia on plasma antioxidants and biomarkers of endothelial health in young, healthy individuals. Vasc Health Risk Manag 2008, 4:213-222.
195. Blum A., Monir M., Khazim K., Peleg A., Blum N. Tomato-rich (Mediterranean) diet does not modify inflammatory markers. Clin Invest Med 2007, 30:E70-E74.
196. Xu X.R., Zou Z.Y., Xiao X., Huang Y.M., Wang X., Lin X.M. Effects of lutein supplement on serum inflammatory cytokines, ApoE and lipid profiles in early atherosclerosis population. J Atheroscler Thromb 2013, 20:170-177.
197. Vaisman N., Haenen G.R., Zaruk Y., Verduyn C., Bindels J.G., Verlaan S., et al. Enteral feeding enriched with carotenoids normalizes the carotenoid status and reduces oxidative stress in long-term enterally fed patients. Clin Nutr 2006, 25:897-905.
198. Watzl B., Kulling S.E., Möseneder J., Barth S.W., Bub A. A 4-wk intervention with high intake of carotenoid-rich vegetables and fruit reduces plasma C-reactive protein in healthy, nonsmoking men. J Nutr 2011, 141:1827-1833.
199. Crane T.E., Kubota C., West J.L., Kroggel M.A., Wertheim B.C., Thomson C.A. Increasing the vegetable intake dose is associated with a rise in plasma carotenoids without modifying oxidative stress or inflammation in overweight or obese postmenopausal women. J Nutr 2011, 141:1827-1833.
200. Talvas J., Caris-Veyrat C., Guy L., Rambeau M., Lyan B., Minet-Quinard R., et al. Differential effects of lycopene consumed in tomato paste and lycopene in the form of a purified extract on target genes of cancer prostatic cells. Am J Clin Nutr 2010, 91:1716-1724.
201. Markovitch D., Tyrrell R.M., Tauler P., Frystyk J., Stokes K., Thompson D. Lycopene supplementation (passata sauce) reduces apoptosis but does not affect oxidant-responsive heme oxygenase-1 in human lymphocytes. Nutrition 2009, 25:668-675.
202. McEneny J., Wade L., Young I.S., Masson L., Duthie G., McGinty A., et al. Lycopene intervention reducesinflammation and improves HDL functionality inmoderately overweight middle-aged individuals. J Nutr Biochem 2013, 24:163-168.
203. Shi J., Kakuda Y., Yeung D. Antioxidative properties of lycopene and other carotenoids from tomatoes: synergistic effects. Biofactors 2004, 21:203-210.
204. Liu D., Shi J., Ibarra A.C., Kakuda Y., Xue S.J. The scavenging capacity and synergistic effects of lycopene, vitamin E, vitamin C, and beta-carotene mixtures on the DPPH free radical. LWT 2008, 41:1344-1349.
205. Palozza P., Calviello G., Serini S., Maggiano N., Lanza P., Ranelletti F.O., et al. Beta-carotene at high concentrations induces apoptosis by enhancing oxy-radical production in human adenocarcinoma cells. Free Radic Biol Med 2001, 30:1000-1007.
206. Kiningham K.K., Cardozo Z.A., Cook C., Cole M.P., Stewart J.C., Tassone M., et al. All-trans-retinoic acid induces manganese superoxide dismutase in human neuroblastoma through NF-kappaB. Free Radic Biol Med 2008, 44:1610-1616.
207. Bian Q., Gao S., Zhou J., Qin J., Taylor A., Johnson E.J., et al. Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression ofinflammation-related genes in retinal pigment epithelial cells. Free Radic Biol Med 2012, 53:1298-1307.
208. Wu J., Zhang Y., Liu Q., Zhong W., Xia Z. All-trans retinoic acid attenuates airway inflammation by inhibiting Th2 and Th17 response in experimental allergic asthma. BMC Immunol 2013, 14:28.
209. Schuster G.U., Kenyon N.J., Stephensen C.B. Vitamin A deficiency decreases and high dietary vitamin A increases disease severity in the mouse model of asthma. J Immunol 2008, 180:1834-1842.
210. Lee W., Ku S.K., Bae J.W., Bae J.S. Inhibitory effects of lycopene on HMGB1-mediated pro-inflammatory responses in both cellular and animal models. Food Chem Toxicol 2012, 50:1826-1833.
211. Li Z., Wong A., Henning S.M., Zhang Y., Jones A., Zerlin A., et al. Hass avocado modulates postprandial vascular reactivity and postprandial inflammatory responses to a hamburger meal in healthy volunteers. Food Funct 2013, 4:384-391.
212. Osganian S.K., Stampfer M.J., Rimm E., Spiegelman D., Manson J.E., Willett W.C. Dietary carotenoids and risk of coronaryartery disease in women. Am J Clin Nutr 2003, 77:1390-1399.
213. Tak P.P., Firestein G.S. NF-kappaB: a key role in inflammatory diseases. J Clin Invest 2001, 107:7-11.
214. Jung K.A., Kwak M.K. The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules 2010, 15:7266-7291.
215. Herlaar E., Brown Z. p38 MAPK signalling cascades in inflammatory disease. Mol Med Today 1999, 5:439-447.